Reglagene
PrivateLast Round
Series A
Extension
Dec 19, 2023
Est. Valuation
$25.4M
Total Funding Raised
$7.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Reglagene is a therapeutics company that develops brain-penetrant small-molecule medicines for the treatment of brain cancers and other neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reglagene Comparables
Compare Reglagene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 84% | |
| Rgenta Therapeutics | 80% | |
| Gertrude Biomedical | 79% | |
Reglagene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 19, 2023 | ||||
| Convertible Debt | Jun 1, 2021 | ||||
| Series A | Feb 1, 2021 | ||||
| Grant | Mar 9, 2020 | ||||
| Grant | Dec 19, 2019 | ||||
Grant | Sep 1, 2018 |
Reglagene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Tech Coast Angels | Series A Extension |
| Viva BioInnovator | Series A Extension |
| CANCER FUND | Series A, Series A Extension |
| Arizona Commerce Authority | Grant |
| TCA Venture Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 808% MoM, from 122 to 1.1K.
- Apr 20, 2026
Monthly visitors grew 37% MoM.
Reglagene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reglagene's valuation, stock price, and market status.